GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
April 10 - Hedge Fund Investor Letters, News
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Keep Reading →
April 8 - Hedge Funds, News
On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns surrounding the current tariff policies.
Keep Reading →
April 7 - Hedge Funds, News
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Keep Reading →
March 31 - Hedge Funds, News
Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street.
Keep Reading →
March 30 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American...
Keep Reading →
March 19 - News
After two years of 25%+ gains, some investors worry that stocks are overvalued.
Keep Reading →
March 15 - Hedge Funds, News
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Keep Reading →
March 15 - Hedge Funds, News
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Keep Reading →
March 14 - Hedge Funds, News
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter.
Keep Reading →
March 12 - Hedge Fund Investor Letters, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Keep Reading →
February 22 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2024 Earnings Call Transcript February 10, 2025Vertex Pharmaceuticals Incorporated misses on earnings expectations.
Keep Reading →
February 11 - News, Transcripts
Jim Cramer, the host of Mad Money, has been considering the uncertainty surrounding 2025 and the ongoing macroeconomic challenges that are sparking important questions.
Keep Reading →
January 30 - Hedge Funds, News
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 investor letter.
Keep Reading →
January 10 - Hedge Fund Investor Letters, News
Healthcare has been one of Jim Cramer's favorite topics lately.
Keep Reading →
December 31 - News
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure...
Keep Reading →
December 24 - News
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Keep Reading →
December 24 - Hedge Funds, News
The Federal Reserve created quite a bit of turmoil in the stock market on Wednesday when despite cutting interest rates, it signaled to investors that the journey to low rates...
Keep Reading →
December 23 - News
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third quarter 2024, investor letter.
Keep Reading →
December 19 - Hedge Fund Investor Letters, News
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success...
Keep Reading →
December 18 - Hedge Funds, News
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2024 Earnings Call Transcript November 4, 2024Vertex Pharmaceuticals Incorporated beats earnings expectations.
Keep Reading →
November 5 - News, Transcripts
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Keep Reading →
October 6 - Hedge Funds, News
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
October 3 - Hedge Fund Investor Letters, News
In a recent episode of Mad Money, Jim Cramer offers a perspective on Nvidia and its recent market behavior on Wednesday's episode of Mad Money, presenting a straightforward analysis...
Keep Reading →
August 30 - Hedge Funds, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript August 1, 2024Vertex Pharmaceuticals Incorporated misses on earnings expectations.
Keep Reading →
August 3 - News, Transcripts
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Keep Reading →
June 24 - Hedge Funds, News
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ...
Keep Reading →
June 19 - Hedge Funds, News
Venu Krishna, Head of U.S.
Keep Reading →
June 18 - Hedge Funds, News
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Keep Reading →
June 14 - Hedge Funds, News
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading...
Keep Reading →
June 3 - Hedge Funds
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Keep Reading →
May 8 - Market Movers, News
Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07.
Keep Reading →
May 7 - News, Transcripts
In this article, we discuss the 23 most profitable stocks of the last 12 months.
Keep Reading →
May 4 - Hedge Funds, News
In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
Keep Reading →
March 17 - News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
Aristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity Strategy” fourth quarter 2023 investor letter.
Keep Reading →
March 4 - Hedge Fund Investor Letters, News
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Keep Reading →
February 23 - Lists, News
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Keep Reading →
February 17 - Hedge Funds, News
In this article, we discuss the top 5 CRISPR stocks to invest in.
Keep Reading →
February 10 - News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
February 9 - Hedge Fund Investor Letters, News
Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.
Keep Reading →
February 6 - News, Transcripts
The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.
Keep Reading →
January 22 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Keep Reading →
December 12 - Industries, Lists, News
In this article, we discuss Jim Simons and his top 10 stock picks.
Keep Reading →
December 8 - Hedge Funds, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
